A3P

Log in

Sales of drugs in France up by 2,1% in 2016

The pharmaceutical industry's turnover increased last year in France, but this growth would be "trompe-l'oeil", said Tuesday the federation of the sector (Leem), which hopes of the new government "a policy of rupture "favoring therapeutic innovation.

Read more...

Novartis: CEO to be replaced in 2018

Swiss pharmaceutical giant Novartis said Monday that Joseph Jimenez, its current CEO, will step down next year and will be replaced by Vasant Narasimhan, chief medical officer and global director of drug development.

Read more...

USA: Green light from the FDA at the first gene therapy

The US Food and Drug Administration (FDA) on Wednesday approved the first gene therapy in the United States.

Read more...

Bertin Pharma sells its pharmaceutical and biotech activities

Bertin Pharma, a subsidiary of Bertin Technologies specializing in pharmaceutical R & D services, sold its pharmaceutical and biotech services activities to two French companies specializing in the field, according to a statement published on Thursday.

Read more...

Vaccines: Sanofi completes acquisition of American Protein Sciences

Sanofi announced on Monday that it had finalized the acquisition of American Protein Sciences for up to 750 million, an operation that should allow it to strengthen in influenza vaccines in the United States.

Read more...

a3p-100pxhaut logo

 fren

Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb here )


  group    administrators A3P
    
& Project Managers

letter   newsletter A3P